Correspondence on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’ by Smeenk et al
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2025-07-01
|
| Serija: | Journal for ImmunoTherapy of Cancer |
| Online dostop: | https://jitc.bmj.com/content/13/7/e011895.full |
| Oznake: |
Brez oznak, prvi označite!
|